Biosafety & Risk Mitigation in Clinical Labs
29 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Considering the historical context of laboratory-acquired infections in the 19th century and the evolution of biosafety practices, which statement most accurately reflects the contemporary paradigm of occupational risk mitigation in high-containment clinical laboratories?

  • While technological advancements have significantly reduced the incidence of overt laboratory-acquired infections, the insidious nature of subclinical exposures and long-latency pathogens necessitates a continued, albeit modified, reliance on historical epidemiological data for comprehensive risk management.
  • The shift from 19th-century empirical observations to evidence-based biosafety frameworks has led to a complete decoupling of historical infection patterns from current risk profiles, allowing for predictive modeling based solely on contemporary exposure data and agent-specific pathogenicity metrics.
  • Modern clinical laboratories, leveraging advanced engineering controls and stringent protocols, have effectively eliminated the occupational risk of infection, rendering historical data largely irrelevant to contemporary risk assessments.
  • Despite progress in biosafety infrastructure and procedural rigor, the intrinsic variability in human factors and the emergence of novel or resistant biological agents mean that the fundamental nature of occupational infection risk remains qualitatively similar to that observed in the 19th century, demanding a constant state of heightened vigilance. (correct)

In the context of a multinational pharmaceutical corporation establishing a novel research facility focused on viral vector gene therapy, which of the following considerations regarding legislative frameworks for biological safety would be paramount in ensuring global operational compliance and minimizing legal and ethical liabilities across diverse regulatory jurisdictions?

  • Implementing a globally harmonized biosafety program based exclusively on the World Health Organization's (WHO) International Health Regulations (IHR) to ensure universal acceptance and preempt potential conflicts arising from disparate national regulations.
  • Prioritizing adherence to the most permissive national biosafety guidelines among all operational locations to streamline protocol standardization and minimize bureaucratic complexities, thereby fostering operational efficiency and agility.
  • Adopting a dynamic, risk-based biosafety framework that incorporates the most stringent regulatory requirements from each jurisdiction of operation, allowing for localized protocol adaptations while maintaining a baseline of maximal safety and ethical probity. (correct)
  • Establishing a centralized biosafety oversight committee empowered to interpret and selectively apply national regulations based on a technocratic assessment of perceived risk, thereby optimizing resource allocation and avoiding redundant compliance measures across different sites.

Given the hierarchical classification of biological agents based on risk groups, and considering a scenario involving a research laboratory working with a Risk Group 3 bacterial pathogen exhibiting enhanced transmissibility due to a recently acquired plasmid, which of the following control measure strategies would represent the most judicious and comprehensive approach to mitigate potential occupational and environmental hazards?

  • Maintaining standard Risk Group 3 biosafety protocols but implementing enhanced active surveillance for laboratory personnel and the surrounding community, relying on rapid diagnostic capabilities to detect and contain any potential spillover events, while continuing research under heightened observation.
  • Reclassifying the modified bacterial pathogen as a provisional Risk Group 4 agent pending comprehensive risk reassessment by a national biosafety authority, immediately suspending all non-essential research activities, and initiating a facility-wide biosafety audit.
  • Augmenting standard Risk Group 3 biosafety practices with enhanced personal protective equipment (PPE) protocols, focusing primarily on respiratory protection and secondary containment barriers, while maintaining standard laboratory access controls.
  • Implementing a 'Risk Group 3+' enhanced biosafety level protocol, incorporating elements of Risk Group 4 practices such as mandatory personnel decontamination procedures, unidirectional airflow systems, and stringent waste management, alongside enhanced medical surveillance. (correct)

In the context of advanced microbiological safety cabinet (MSC) technology, specifically considering Class III MSCs integrated within a large-scale biopharmaceutical manufacturing facility producing live viral vaccines, which statement most accurately describes a critical operational and validation parameter distinguishing Class III MSCs from other containment devices in ensuring product sterility and operator safety?

<p>Class III MSCs are uniquely characterized by their gas-tight enclosure and physical separation of the operator from the work zone, necessitating remote manipulation via glove ports and a double-door autoclave for material transfer, thus providing absolute containment critical for high-risk vaccine production. (D)</p> Signup and view all the answers

Considering the ethical and biosafety ramifications of contemporary genetic modification technologies, specifically CRISPR-Cas9 gene editing applied to human somatic cells for therapeutic purposes, which of the following scenarios presents the most complex and multifaceted challenge regarding risk assessment and regulatory oversight, demanding the most nuanced and ethically informed biosafety approach?

<p>Application of CRISPR-Cas9 to modify human somatic cells to confer resistance to a highly prevalent, rapidly evolving viral pathogen within a community-based healthcare setting, potentially raising concerns about unintended ecological consequences and equitable access to advanced biotechnologies. (B)</p> Signup and view all the answers

In a research laboratory utilizing genetically modified organisms (GMOs), a novel bacterium exhibits characteristics placing it between ACDP Hazard Group 2 and 3. Given the precautionary principle and the potential for unforeseen phenotypes arising from genetic modification, what is the MOST defensible initial SACGM Activity Class assignment, considering both employee safety and environmental stewardship?

<p>Activity Class 3, due to the inherent uncertainties associated with GMOs and the potential for community spread, warranting heightened containment. (B)</p> Signup and view all the answers

A laboratory is working with a Risk Group 3 bacterial strain for which effective prophylaxis exists. Following an incident involving a spill outside of a designated biosafety cabinet, which course of action BEST balances immediate risk mitigation with long-term containment strategy?

<p>Administer prophylactic treatment to potentially exposed personnel, implement spill decontamination using a validated protocol, and conduct a thorough investigation into the incident, revising SOPs as necessary. (B)</p> Signup and view all the answers

A research team is investigating a novel viral vector for gene therapy that exhibits enhanced tropism for human cells in vitro. Although preliminary data suggests minimal replication competence in vivo, ethical considerations dictate a comprehensive safety assessment. What multi-faceted approach BEST addresses the potential risks associated with unintended vector shedding and integration?

<p>Conduct extensive <em>in vivo</em> biodistribution studies in relevant animal models, employ quantitative PCR to assess vector shedding in bodily fluids, implement stringent waste disposal protocols, and utilize replication-competent virus detection assays. (B)</p> Signup and view all the answers

During a long-term experiment involving a Hazard Group 3 bacterial pathogen, the autoclave malfunctions, potentially compromising the sterilization of biohazardous waste. Considering the immediate and latent risks, what is the MOST responsible and comprehensive course of action?

<p>Quarantine the potentially unsterilized waste, implement emergency repair of the autoclave, validate the repaired autoclave's efficacy with biological indicators, and re-autoclave the waste, followed by a thorough review of waste management protocols. (D)</p> Signup and view all the answers

A scientist consistently disregards the lab's SOPs when working with infectious materials, claiming their personal technique is superior and poses no risk. Despite repeated warnings, the behavior persists. What is the MOST appropriate and ethically justifiable course of action for the laboratory director?

<p>Implement mandatory retraining on SOPs and biosafety practices, followed by direct observation of the scientist's technique, and escalate disciplinary actions if non-compliance continues. (B)</p> Signup and view all the answers

Consider a scenario where a new regulation mandates more stringent waste disposal protocols for all biological agents, including a specific requirement for on-site incineration of Hazard Group 4 pathogens. However, a research facility lacks the infrastructure and resources for on-site incineration. What multifaceted strategy BEST ensures compliance with the new regulation while minimizing disruption to ongoing research activities?

<p>Collaborate with nearby facilities that have incineration capabilities, establish a secure and validated transport protocol for biohazardous waste, and update waste disposal SOPs accordingly. (C)</p> Signup and view all the answers

A research laboratory is repurposing a former chemical storage area into a BSL-3 facility. Despite thorough decontamination efforts, residual traces of a highly persistent, non-volatile chemical contaminant are detected on surfaces. How should the risk assessment and facility adaptation proceed to ensure biosafety?

<p>Conduct a comprehensive risk assessment addressing the synergistic effects of the chemical contaminant and biological agents, implement engineering controls to minimize exposure, and establish strict personal protective equipment (PPE) requirements. (A)</p> Signup and view all the answers

In a high-throughput screening laboratory, robotic systems are used to handle Risk Group 2 organisms. A power outage causes an unexpected system shutdown, resulting in a spill of infectious material within the robotic enclosure. Given the automated nature of the system and potential for widespread contamination, what is the OPTIMAL response?

<p>Activate the emergency power supply, remotely initiate a validated decontamination cycle of the entire robotic system, and restrict access until decontamination is confirmed by biological indicators. (B)</p> Signup and view all the answers

Given a novel, highly virulent strain of Yersinia pestis (plague) engineered to express a modified surface protein that enhances its ability to bypass alveolar macrophage phagocytosis, and considering its classification as a Hazard Group 3 (HG3) organism, which of the following containment strategies represents the MOST critical deviation from standard HG3 protocols that could lead to a laboratory-acquired infection via aerosol transmission?

<p>Waiving the requirement for negative air pressure within the laboratory suite, provided that all procedures are conducted within a Class II Microbiological Safety Cabinet (MSC) certified for HG3 organisms. (D)</p> Signup and view all the answers

A researcher is conducting a series of experiments involving Foot & Mouth Disease Virus (FMDV) within a SAPO4 designated lab space. Knowing FMDV's classification, which of the following actions would represent the MOST critical breach of containment, posing the greatest risk of environmental release and subsequent economic impact on livestock industries?

<p>Ventilating the SAPO4 laboratory space directly into the external environment without HEPA filtration of the exhaust air, predicated on the assumption that FMDV is primarily transmitted through direct contact. (C)</p> Signup and view all the answers

Consider a scenario where a research team is genetically modifying E. coli K12 (HG1) to express a novel virulence factor derived from Bacillus anthracis, substantially increasing its pathogenicity. While still classified as contained use, which of the following changes to standard HG1 practices would be LEAST sufficient to mitigate the heightened risk associated with the genetically modified organism (GMO)?

<p>Continuing to permit eating and drinking within the laboratory space, contingent upon strict adherence to hand hygiene protocols and surface disinfection practices before and after. (B)</p> Signup and view all the answers

In a high-throughput screening laboratory, a researcher is employing vigorous pipetting to resuspend a large number of cell pellets infected with Influenza (H1N1)pdm09. Despite working within a Class II MSC, the researcher consistently observes significant aerosol generation. Which of the following modifications to the experimental protocol would MOST effectively minimize aerosol exposure, while maintaining throughput and data integrity?

<p>Utilizing pipette tips equipped with aerosol-barrier filters and reducing the pipetting speed, while increasing the number of aspiration/dispense cycles to achieve adequate resuspension. (C)</p> Signup and view all the answers

Following an accidental needlestick injury sustained during the handling of a culture infected with Plasmodium falciparum (malaria HG3*), a researcher immediately initiates post-exposure prophylaxis. Considering the potential for delayed or atypical presentation of malaria due to drug resistance or other factors, which of the following actions represents the MOST comprehensive and proactive approach to long-term health monitoring and management?

<p>Undergoing monthly quantitative PCR (qPCR) assays for <em>P. falciparum</em> DNA for six months, coupled with symptom monitoring, to detect low-level parasitemia that may evade standard diagnostic methods. (A)</p> Signup and view all the answers

A laboratory director is tasked with establishing a new Biosafety Level 4 (BSL-4) facility for research on Ebola haemorrhagic fever virus (HG4). Given the inherent risks associated with handling such a highly dangerous pathogen, which of the following strategies should be prioritized to MOST effectively minimize the probability of a containment breach leading to community exposure?

<p>Employing a continuous air monitoring system with real-time PCR detection of Ebola RNA, coupled with automated shutdown of facility ventilation upon detection of the virus. (B)</p> Signup and view all the answers

A researcher is planning to introduce a gene encoding a potent, but non-transmissible, toxin derived from a plant pathogen into E. coli K12. The toxin's mechanism of action involves disruption of mitochondrial function in eukaryotic cells. Which of the following considerations is MOST critical during the risk assessment required by GMO (Contained Use) Regulations?

<p>Quantifying the toxin production level in the modified <em>E. coli</em> strain and evaluating the potential for accidental exposure via ingestion, inhalation, or absorption, including potential allergenic effects. (D)</p> Signup and view all the answers

During a training session on sharps safety at a Containment Level 2 (CL2) laboratory, a new technician argues that resheathing needles is acceptable when transporting multiple samples from one biosafety cabinet to another within the same laboratory suite, as it reduces the risk of accidental puncture during transport. How should the safety officer respond based on established best practices and relevant training principles?

<p>Emphasize that resheathing needles is strictly prohibited under all circumstances due to the increased risk of needlestick injury during the resheathing process, promoting the use of a sharps container. (D)</p> Signup and view all the answers

Considering the classification criteria for biological agents, which of the following scenarios presents the most complex challenge in assigning a hazard group, requiring the most nuanced risk assessment?

<p>A novel, genetically modified virus demonstrates high infectivity in vitro but exhibits significantly reduced virulence in vivo, with potential for limited human-to-human transmission. (A)</p> Signup and view all the answers

In the context of containment laboratories, what is the most critical engineering control for preventing the release of Hazard Group 3 (HG3) biological agents via aerosol transmission, considering both routine operations and potential failure modes?

<p>Installation of redundant HEPA filtration systems in the exhaust air stream, combined with real-time aerosol monitoring and automated shutdown procedures in case of filter breach. (C)</p> Signup and view all the answers

When evaluating the necessity of a Hazard Group 4 (HG4) containment laboratory versus a high-containment facility for HG3 agents with enhanced transmission potential, what specific risk assessment parameter carries the most decisive weight in justifying the additional investment and security measures associated with HG4 containment?

<p>The potential for the agent to establish a sustained transmission cycle in the general community, leading to widespread morbidity and mortality in the absence of intervention. (B)</p> Signup and view all the answers

During a large-scale spill of a concentrated viral stock (Hazard Group 3) within a Class III biological safety cabinet, which decontamination strategy minimizes the risk of both personnel exposure and equipment damage, while ensuring complete viral inactivation?

<p>Vaporized hydrogen peroxide (VHP) fumigation of the cabinet, utilizing a validated cycle that accounts for the organic load and material compatibility, followed by aeration. (D)</p> Signup and view all the answers

Considering the complexities of working with genetically modified organisms (GMOs) in a research setting, what is the single most important factor in determining whether an experiment involving a modified Hazard Group 2 bacterium should be conducted at Containment Level 2 (CL2) versus Containment Level 3 (CL3)?

<p>The nature of the genetic modification and its potential impact on the bacterium's virulence, transmissibility, and host range: any modification that increases these factors necessitates CL3. (D)</p> Signup and view all the answers

In the event of a confirmed laboratory-acquired infection (LAI) involving a Hazard Group 3 bacterial agent, what immediate action is most crucial for preventing secondary transmission within the surrounding community, assuming the infected individual is exhibiting mild, non-specific symptoms?

<p>Implementation of source control measures, such as respiratory etiquette and voluntary self-isolation, combined with active surveillance for symptom development among contacts. (B)</p> Signup and view all the answers

A researcher is developing a novel diagnostic assay that requires the cultivation of a previously uncharacterized virus isolated from bats. Preliminary data suggests the virus may have the potential to infect human cells in vitro, but its pathogenicity and transmissibility in vivo are unknown. What is the MOST appropriate initial containment strategy for handling this virus?

<p>Conduct an in-depth risk assessment, considering factors such as viral tropism, replication kinetics, and potential routes of exposure, and implement the containment measures deemed appropriate based on the assessment outcome. (C)</p> Signup and view all the answers

You are tasked with designing a new suite of containment laboratories. One lab will handle Risk Group 2 and 3 bacteria, and a separate lab will handle Risk Group 4 viruses. Both labs require effluent decontamination systems. Which principle is MOST critical for designing and validating the Risk Group 4 effluent decontamination system, compared to the Risk Group 2/3 system?

<p>Ensuring complete inactivation of ALL potential pathogens with a wide margin of safety, and continuous monitoring of system performance to detect ANY potential breaches or failures. (B)</p> Signup and view all the answers

Flashcards

Biosafety

Study of safe handling of biological agents to minimise risk in labs.

Occupational Infection Risk

Workers in medical labs face a significant risk of infection at work.

Goal of Biosafety

Minimise risks associated with biological agents.

Control Measures (Biosafety)

Physical and procedural safeguards to reduce exposure to biohazards.

Signup and view all the flashcards

Microbiological Safety Cabinets

Specialised containment to prevent the escape of hazardous microbes.

Signup and view all the flashcards

E. coli K12 (HG1)

A lab strain of E. coli, designated as Hazard Group 1.

Signup and view all the flashcards

Plasmodium falciparum (HG3)

Malaria-causing parasite, classified as Hazard Group 3.

Signup and view all the flashcards

Lab Coats

Mandatory in CL1, CL2 and CL3 labs to protect personnel.

Signup and view all the flashcards

Routes of Infection

Inoculation, inhalation, absorption and ingestion.

Signup and view all the flashcards

Sharps

Needles, razor blades, scalpels and broken glass.

Signup and view all the flashcards

Aerosol-Generating Procedures

Techniques like centrifugation, sonication and vigorous pipetting.

Signup and view all the flashcards

Class II MSC

Provides operator and sample protection; effective for controlling aerosols; can be used up to CL3.

Signup and view all the flashcards

Genetic Modification

Introducing foreign DNA into an organism through non-natural methods.

Signup and view all the flashcards

Containment Labs

Labs designed to control aerosols, inactivate waste, and maintain negative pressure, especially in the 21st century.

Signup and view all the flashcards

21st Century Containment Labs

Labs with the ability to fumigate and ensure biosecurity.

Signup and view all the flashcards

Biological Agents

Bacteria, parasites, viruses, and fungi, including genetically modified versions, especially those contaminating human, animal, or plant material (e.g., blood) and can cause disease.

Signup and view all the flashcards

Hazard Groups

A classification system (1-4) based on disease severity, risk to workers, community transmission likelihood, and availability of treatments/vaccines.

Signup and view all the flashcards

Hazard Group 1

Unlikely to cause human disease.

Signup and view all the flashcards

Hazard Group 2

Can cause human disease, may be a hazard to employees, unlikely to spread to the community, and usually has effective treatments.

Signup and view all the flashcards

Hazard Group 3

Can cause severe human disease, may be a serious hazard to employees, can spread to the community, and usually has effective treatments.

Signup and view all the flashcards

Hazard Group 4

Causes severe human disease, a serious hazard to employees, likely to spread to the community, and usually has no effective treatments.

Signup and view all the flashcards

Containment Measures

Measures implemented to minimise risks associated with biological agents.

Signup and view all the flashcards

Risk Assessment Outcome

Assigning the appropriate level of containment and class to the activity based on risk.

Signup and view all the flashcards

Inactivation of Agents

Neutralising biological agents in waste to eliminate risks.

Signup and view all the flashcards

Safe Working Practices

Knowing the risks and safety procedures for the lab.

Signup and view all the flashcards

Study Notes

  • Biological safety is a major risk for clinical and research laboratories
  • Dr Ian Graham is the University Biosafety Advisor

Contents

  • The presentation covers brief history of lab infections
  • Legislative framework
  • Classification of biological agents
  • Steps to minimize risk with control measures
  • Microbiological safety cabinets
  • Genetic modification
  • Sources of information

Occupational Infection (19th C)

  • Woolsorters' disease required precautionary regulations in Bradford

Importance of Biosafety

  • Medical laboratory workers continue to experience a considerable risk of developing an occupationally acquired infection
  • Improvements in staff safety and health care are still necessary
  • Mouth pipetting was recognized as a serious hazard as far back as 1915
  • In the 1960's 62% of laboratories still mouth pipetted, and this figure had not improved by 1977

Headline News

  • A first U.S. scientist died of plague in 50 years while working in labs with 'harmless' bacteria
  • A smallpox victim died in Birmingham after mystery killer virus stays unsolved

The Legislative Framework

  • Health and Safety at Work etc. Act 1974
  • Guidance for license holders on the containment and control of specified animal pathogens
  • Genetically Modified Organisms (Contained Use) Regulations 2014
  • Control of substances hazardous to health

21st Century Containment Labs

  • These labs feature control of aerosols, waste inactivation, and negative pressure
  • The labs also have the ability to fumigate and operate with tight biosecurity

Agents of Concern

  • Labs need protecting from bacteria, parasites, viruses, and fungi
  • Genetically modified versions are also of concern
  • These include agents contaminating human, animal, or plant material (especially blood)
  • These may cause disease in humans, animals, or plants

Classification of biological agents

  • Classified into Hazard Groups 1-4
  • Classification based on the severity of disease, risk to workers, likelihood of community transmission, and availability of vaccines or effective treatments
  • Unlisted biological agents are usually Hazard Group 1

Hazard Groups

  • Group 1 poses unlikely risk of causing human disease
  • Group 2 can cause human disease and may be a hazard to employees, but unlikely to spread to the community
    • Effective prophylaxis or treatment is usually available
  • Group 3 can cause severe human disease and may be a serious hazard to employees, and can spread to the community
    • Effective prophylaxis or treatment is usually available
  • Group 4 causes severe human disease and is a serious hazard to employees
    • Likely to spread to the community
    • Usually no effective prophylaxis or treatment available

Examples of Hazard Groups

  • Mycobacterium tuberculosis = HG3
  • E. coli K12 (lab strain) = HG1
  • Plasmodium falciparum (malaria) = HG3*
  • Foot & Mouth disease virus = HG1/SAPO4
  • Influenza (H1N1)pdm09 = HG2
  • Ebola hemorrhagic fever virus = HG4

Features of Containment Labs

  • Level 1 bans eating, drinking, applying cosmetics
  • Level 1 surfaces are impervious and easy to clean, bench only
  • Level 2 requires wearing of lab coats, validates inactivation of GM organisms, and includes validated inactivation of GM organisms
  • Levels 2 and 3 require restricted access
  • Level 3 includes impermeable bench and floor surfaces, dedicated equipment, and autoclave in suite
  • Level 3 requires use of safety cabinet if aerosols produced
  • Level 3 is sealable for fumigation and requires written training records

Routes of Infection

  • Inoculation from skin breaks or punctures
  • Inhalation of aerosols
  • Absorption through skin and/or eyes
  • Ingestion of water-borne materials
  • Risks need to be managed accordingly

Sharps

  • Sharps are the most likely way of getting a pathogen into your system
  • Sharps can also cause injuries
  • Correct storage, use, and disposal of sharps is vital
  • Sharps include needles, razor blades, scalpels, and glass (including Pasteur pipettes)
  • Do not resheath needles
  • Training for sharps at CL2

Managing Aerosols

  • There is a high Risk if agent is infectious by airborne route
  • Also consider environmental protection
  • Techniques that generate aerosols need to be managed
  • Minimizing Centrifugation, Sonication, Flow cytometry & cell sorting (FACS) and Vigorous pipetting action
  • Control by the use of MSCs

Class II MSC

  • Offer operator and sample protection
  • Can be used up to CL3
  • Most common mode of primary containment
  • Are the best way of controlling infectious aerosols
  • Require correct set-up and use for effective operation

Genetic Modification

  • Genetic modification is introducing foreign DNA into any organism by a method that doesn't occur naturally
  • GMO (Contained Use) Regulations require a risk assessment
    • Identify any hazards from hosts, vectors and inserted DNA
    • What could happen when you combine them?
    • What containment measures are needed to control the risk?
    • Assign the appropriate Containment Level and Class of Activity
    • Seek advice from a GM Safety Committee

Waste Disposal Routes

  • Incorrect disposal of waste can put people and the environment at risk
  • Inactivation of biological agents is vital
    • Physical methods (e.g. autoclaving)
    • Chemical methods (e.g. disinfectants)
  • Need evidence that your method is effective
  • Workers need to know the correct disposal streams for any waste they generate

Summary of Safe Working Practices

  • Do you know what the risk assessment says?
  • Is the lab the correct Containment Level?
  • Have you received training in the techniques and SOPs?
  • Is the use of sharps minimized or justified?
  • Are procedures in place to control aerosol production?
  • What PPE is required, and are you using it?
  • Do you know which waste disposal routes to use?
  • Is the correct validated disinfectant available?
  • Do you know how to react if things go wrong (e.g. spills)?

Sources of information

  • HSE Biosafety website has an approved list of biological agents, information the management & operation of containment labs, SACGM Compendium of guidance, COSHH ACOP & Guidance, GMO Regulations and Guidance, and SAPO Guidance
  • University Biosafety webpages

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

Description

Explores biosafety practices, occupational risk mitigation, and legislative frameworks in laboratories. Focuses on high-containment clinical labs, biological agent classifications, and control measure strategies. Covers multinational pharmaceutical operational compliance.

More Like This

Biosafety Levels and Risk Groups Quiz
112 questions
Biosafety Levels and Risk Groups Quiz
60 questions
Biosafety Levels and Risk Groups Quiz
43 questions
Biosafety Levels and Risk Groups
61 questions
Use Quizgecko on...
Browser
Browser